The general rule for the 3 Hopper Companies is that they will always announce first patient dosed for a new trial and for each new cohort for either IT, IV or a new higher dose. No updates on 2nd, 3rd,..... patients dosed or final patient. Any more info will be released with read outs.
That was clarified by CHM's previous CEO as a general rule signed off by the 3 CEOs.
GLTA
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-117
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $1.065M | 21.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 3926576 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 688134 | 17 |
View Market Depth
| Last trade - 11.12am 18/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |